DX 002
Alternative Names: DX-002Latest Information Update: 28 Jun 2023
At a glance
- Originator GuangDong NewOpp Biopharmaceuticals
- Class Antineoplastics
- Mechanism of Action Prostaglandin E EP2 receptor antagonists; Prostaglandin E EP4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer